GALVmed is delighted to announce it is to receive substantial funding from the UK Department for International Development (DFID) and the Bill and Melinda Gates Foundation.
The US$28 million grant over the next three years will be used to develop systems to improve prevention, diagnosis and treatment for a range of leading livestock diseases in developing countries.
“We are excited to have funding from DFID and the Bill & Melinda Gates Foundation. Their support is an important step toward closing the substantial gap between the need for livestock health mechanisms in the developing world and the amount of funding available to support those initiatives,” said Steve Sloan, chief executive of GALVmed. “We now have the means to facilitate the development and delivery of vital animal health products to populations whose survival depends on healthy livestock.”